Washington SB6183 mandates coverage for FDA-approved HIV antiviral drugs without prior authorization or step therapy for health plans issued or.

Washington SB6183 requires health carriers to cover all FDA-approved HIV antiviral drugs without prior authorization, step therapy, or other utilization management protocols for health plans issued or renewed on or after January 1, 2027. This applies to all health plans providing medical insurance, including those not subject to Title 48 RCW. If therapeutic equivalents are approved by the FDA, coverage is not required for all versions if at least one is covered without prior authorization or step therapy.

Washington SB6183 mandates coverage for FDA-approved HIV antiviral drugs without prior authorization or step therapy for health plans issued or.

Washington SB6183 requires health carriers to cover all FDA-approved HIV antiviral drugs without prior authorization, step therapy, or other utilization management protocols for health plans issued or renewed on or after January 1, 2027. This applies to all health plans providing medical insurance, including those not subject to Title 48 RCW. If therapeutic equivalents are approved by the FDA, coverage is not required for all versions if at least one is covered without prior authorization or step therapy.